乙肝保护性活性和前化基胺的机制
Bailin Li1,2,3, Shengtao Bo4, Zhili Sheng1,2,3
1Key State Laboratory of Plant Diversity and Specialty Crops, Guangdong Provincial Key Laboratory of Applied Botany, Key Laboratory of South China Agricultural Plant Molecular Analysis and Genetic Improvement, South China Botanical Garden, Chinese Academy of Sciences, Guangzhou 510650, China.
甲化 stilbenoids 通过激活无声交配类型信息规则 2 同类-1 (SIRT1) 保护肝脏. 4-C-日拉尼尔氧瑞斯韦拉显示出作为肝脏健康的功能性食品添加剂的强大潜力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 营养科学 营养科学
背景情况:
- 饮食中摄入的prenyllated stilbenoids 已知具有健康益处,包括保护肝脏.
- 它们的肝保护作用背后的具体机制尚未完全理解.
- 无声交配类型信息调节2同类-1 (SIRT1) 是一个关键蛋白质,参与细胞调节和健康.
研究的目的:
- 综合和评估天然前化 stilbenoids 的肝脏保护作用.
- 在这些化合物中识别SIRT1的强有力的激活剂.
- 为了阐明涉及到这些stilbenoids提供的肝脏保护的分子途径.
主要方法:
- 合成了13种天然的前化斯蒂尔贝诺伊德.
- 查SIRT1激活的情况.
- 在实验室研究中,使用棕酸诱导的脂质积累和H2O2诱导的亡模型.
- 对SIRT1-介导通路 (SIRT1-PGC1α,SIRT1-p53-p21,SIRT1-Nrf2) 的分析.
主要成果:
- 与复星相比,4-C-基拉尼尔氧化复星显示出更高的SIRT1激活.
- 这种化合物通过SIRT1-PGC1α通路减轻了脂质积累.
- 它通过SIRT1-p53-p21通路减少了细胞亡,并通过SIRT1-Nrf2.2显示了抗氧化作用.
结论:
- 4-C-日拉尼尔氧瑞斯韦拉是一种强大的SIRT1激活剂,具有显著的肝保护性质.
- 这项研究揭示了前化 stilbenoids 的肝脏益处背后的关键分子机制.
- 这些发现支持了前化 stilbenoids 作为肝脏健康的功能性食品添加剂的潜力.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Protecting Groups for Aldehydes and Ketones: Introduction
Radical Reactivity: Steric Effects
Along with electronic...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...


